<DOC>
	<DOCNO>NCT00019630</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase I trial study effectiveness liposomal doxorubicin treat child refractory solid tumor .</brief_summary>
	<brief_title>Liposomal Doxorubicin Treating Children With Refractory Solid Tumors</brief_title>
	<detailed_description>OBJECTIVES : I . Determine tolerance toxicity profile doxorubicin HCl liposome ( Lipodox ) standard doxorubicin dos dose Lipodox tolerable adult administer every 3 week pediatric patient refractory solid tumor . II . Determine maximum tolerate dose drug patient dose-limiting toxicity observe dos 105 mg/m2 less . III . Determine pharmacokinetics drug patient . IV . Assess cardiotoxicity drug child previously treat free doxorubicin child previously receive doxorubicin . V. Evaluate feasibility use cardiac MRI functional imaging screen tool quantitative assessment doxorubicin-induced cardiotoxicity . VI . Determine serum troponin level useful biomarker doxorubicin-induced myocardial damage . PROTOCOL OUTLINE : This dose-escalation , multicenter study . Patients receive doxorubicin HCl liposome IV 60 minute . Treatment repeat every 4 week maximum 10 course absence disease progression unacceptable toxicity . Cohorts 4-6 patient receive escalate dos doxorubicin HCl liposome maximum tolerate dose ( MTD ) determine . The MTD define dose precede least 2 4 2 6 patient experience dose-limiting toxicity . Patients follow every 3 month 1 year , every 6 month 2 year , annually thereafter . PROJECTED ACCRUAL : A total 21-36 patient accrue study within 1-2 year .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Kidney Neoplasms</mesh_term>
	<mesh_term>Bone Neoplasms</mesh_term>
	<mesh_term>Osteosarcoma</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<criteria>PROTOCOL ENTRY CRITERIA : Disease Characteristics Histologically confirm solid tumor , include limited : Rhabdomyosarcoma soft tissue sarcomas Ewing 's family tumor Osteosarcoma Neuroblastoma Wilms ' tumor Hepatic tumor Germ cell tumor Primary brain tumor Histological confirmation brain stem glioma may waive Refractory standard treatment curative therapy available Measurable evaluable disease Evidence progressive disease prior chemotherapy radiotherapy persistent disease prior surgery Prior/Concurrent Therapy Biologic therapy : At least 1 week since prior colonystimulating factor ( e.g. , filgrastim ( GCSF ) , sargramostim ( GMCSF ) , epoetin alfa ) At least 4 month since prior bone marrow transplantation No concurrent anticancer immunotherapy Chemotherapy : See Disease Characteristics At least 3 week since prior chemotherapy ( 4 week nitrosoureas ) recover Prior anthracyclines adjuvant frontline therapy allow provide : No relapse therapy At least 6 month since last dose Cumulative dose great 400 mg/m2 patient receive bolus administration without concurrent cardioprotectant ( e.g. , dexrazoxane ) receive cardiac irradiation great 450 mg/m2 patient receive either continuous infusion administration concurrent cardioprotectant receive cardiac irradiation No concurrent anticancer chemotherapy Endocrine therapy : Concurrent corticosteroid brain tumorassociated edema allow ( must stable decrease dose least 1 week prior study ) Radiotherapy : See Disease Characteristics At least 4 week since prior radiotherapy recover No 1,500 cGy prior cardiac radiotherapy No prior extensive radiotherapy ( e.g. , craniospinal radiation , total body radiation , radiation half pelvis ) No concurrent anticancer radiotherapy Surgery : See Disease Characteristics Other : No concurrent anticancer investigational agent No concurrent liposomal formulation drug ( e.g. , liposomal amphotericin B ) Patient Characteristics Age : 21 Performance status : ECOG 02 Life expectancy : At least 2 month Hematopoietic : Absolute granulocyte count great 1,500/mm3 Hemoglobin great 8 g/dL Platelet count great 100,000/mm3 Hepatic : Bilirubin normal SGPT great 2 time upper limit normal No significant hepatic dysfunction Renal : Creatinine normal OR Creatinine clearance least 60 mL/min Cardiovascular : Cardiac ejection fraction least 45 % MUGA ( National Cancer Institute patient ) OR Shortening fraction least 28 % echocardiogram ( Children 's Hospital Philadelphia patient ) No significant preexisting cardiac dysfunction ( e.g. , recurrent persistent cardiac dysrhythmia ejection fraction lower limit normal MUGA echocardiogram ) Pulmonary : No significant pulmonary dysfunction Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No clinically significant unrelated systemic illness ( e.g. , serious infection organ dysfunction ) No allergy doxorubicin anthracyclines , egg , egg product , liposomal drug formulation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>June 2002</verification_date>
	<keyword>Ewing 's family tumor</keyword>
	<keyword>Wilms ' tumor</keyword>
	<keyword>adult solid tumor</keyword>
	<keyword>body system/site cancer</keyword>
	<keyword>bone cancer</keyword>
	<keyword>brain tumor</keyword>
	<keyword>cancer</keyword>
	<keyword>central nervous system cancer</keyword>
	<keyword>childhood brain stem glioma</keyword>
	<keyword>childhood brain tumor</keyword>
	<keyword>childhood cancer</keyword>
	<keyword>childhood central nervous system germ cell tumor</keyword>
	<keyword>childhood cerebellar astrocytoma</keyword>
	<keyword>childhood cerebral astrocytoma</keyword>
	<keyword>childhood choroid plexus tumor</keyword>
	<keyword>childhood craniopharyngioma</keyword>
	<keyword>childhood ependymoma</keyword>
	<keyword>childhood extracranial germ cell tumor</keyword>
	<keyword>childhood extragonadal malignant germ cell tumor</keyword>
	<keyword>childhood liver cancer</keyword>
	<keyword>childhood malignant ovarian germ cell tumor</keyword>
	<keyword>childhood malignant testicular germ cell tumor</keyword>
	<keyword>childhood mature immature teratoma</keyword>
	<keyword>childhood medulloblastoma</keyword>
	<keyword>childhood meningioma</keyword>
	<keyword>childhood oligodendroglioma</keyword>
	<keyword>childhood rhabdomyosarcoma</keyword>
	<keyword>childhood soft tissue sarcoma</keyword>
	<keyword>childhood solid tumor</keyword>
	<keyword>childhood supratentorial primitive neuroectodermal pineal tumor</keyword>
	<keyword>childhood visual pathway hypothalamic glioma</keyword>
	<keyword>endocrine cancer</keyword>
	<keyword>gastrointestinal cancer</keyword>
	<keyword>genetic condition</keyword>
	<keyword>kidney tumor</keyword>
	<keyword>kidney/urinary cancer</keyword>
	<keyword>liver intrahepatic biliary tract cancer</keyword>
	<keyword>muscle cancer</keyword>
	<keyword>musculoskeletal cancer</keyword>
	<keyword>neuroblastoma</keyword>
	<keyword>osteosarcoma</keyword>
	<keyword>osteosarcoma/malignant fibrous histiocytoma bone</keyword>
	<keyword>pediatric germ cell tumor</keyword>
	<keyword>previously treat childhood rhabdomyosarcoma</keyword>
	<keyword>recurrent Wilms ' tumor</keyword>
	<keyword>recurrent childhood brain stem glioma</keyword>
	<keyword>recurrent childhood brain tumor</keyword>
	<keyword>recurrent childhood cerebellar astrocytoma</keyword>
	<keyword>recurrent childhood cerebral astrocytoma</keyword>
	<keyword>recurrent childhood ependymoma</keyword>
	<keyword>recurrent childhood liver cancer</keyword>
	<keyword>recurrent childhood malignant germ cell tumor</keyword>
	<keyword>recurrent childhood medulloblastoma</keyword>
	<keyword>recurrent childhood rhabdomyosarcoma</keyword>
	<keyword>recurrent childhood soft tissue sarcoma</keyword>
	<keyword>recurrent childhood supratentorial primitive neuroectodermal pineal tumor</keyword>
	<keyword>recurrent childhood visual pathway hypothalamic glioma</keyword>
	<keyword>recurrent neuroblastoma</keyword>
	<keyword>recurrent osteosarcoma</keyword>
	<keyword>recurrent tumor Ewing 's family</keyword>
	<keyword>solid tumor</keyword>
	<keyword>stage , Ewing 's family tumor</keyword>
	<keyword>stage , Wilms ' tumor</keyword>
	<keyword>stage , childhood extracranial germ cell tumor</keyword>
	<keyword>stage , childhood liver cancer</keyword>
	<keyword>stage , childhood medulloblastoma</keyword>
	<keyword>stage , childhood rhabdomyosarcoma</keyword>
	<keyword>stage , childhood soft tissue sarcoma</keyword>
	<keyword>stage , neuroblastoma</keyword>
	<keyword>stage , osteosarcoma</keyword>
	<keyword>stage/type , childhood brain tumor</keyword>
	<keyword>unspecified childhood solid tumor , protocol specific</keyword>
</DOC>